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TLD Position Measured Dose (Gy) Planning Dose (Gy) Deviation Simulated Dose (Gy) Deviation 
Prostate (Approx. Isocentre) 1.929 ± 0.62% 2.021 4.55% 1.929 ± 3.41% - 
Left Femoral Head 1.097 ± 0.98% 1.120 2.05% 1.100 ± 3.46% 0.27% 
Right Femoral Head 1.063 ± 1.02% 1.120 5.09% 1.089 ± 2.48% 2.48% 
Left Seminal Vesicle 1.974 ± 1.08% 2.087 5.41% 1.982 ± 1.94% 0.39% 
Right Seminal Vesicle 1.986 ± 0.94% 2.086 4.79% 1.968 ± 1.89% 0.91% 
Base of Seminal Vesicles 1.988 ± 0.87% 2.087 4.74% 1.965 ± 1.16% 1.14% 
Posterior Prostate (Rectal Wall) 1.946 ± 1.28% 2.063 5.67% 1.968 ± 2.74% 1.13% 
Prostate Apex 1.908 ± 0.80% 2.010 5.07% 1.931 ± 2.98% 1.21% 
Anorectal Sphincter (Dentate Line) 1.187 ± 1.08% 1.205 1.49% 1.208 ± 2.24% 1.80% 
Right Pelvis Side Wall (Out Of Field) 0.082 ± 0.92% 0.064 28.13% 0.079 ± 6.64% 3.36% 
Ion Chamber Measured Dose Simulated Dose Deviation 
Central axis (2 cm depth) 1.564 1.414 ± 13.5% 10.6% 
Central axis (5 cm depth) 1.399 1.383 ± 2.7% 1.2% 
Central axis (8 cm depth) 1.159 1.149 ± 2.8% 0.9% 
Central measurement 1.000 1.000 ± 2.0% - 
Inside Penumbra 1.352 1.229 ± 23.8% 10.0% 
Outside Penumbra 0.089 0.296 ± 88.4% 69.9% 
Outside Field 0.014 0.011 ± 15.4% 27.3% 
Table 3. Elvis Phantom Measurements 
Table 1. Homogeneous Quasar Phantom Measurements 
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Introduction 
 
Recent advances in the planning and delivery of radiotherapy treatments have resulted in improvements in the accuracy and precision with which therapeutic radiation can be administered. As the complexity of the treatments 
increases it becomes more difficult to predict the dose distribution in the patient accurately. Monte Carlo methods have the potential to improve the accuracy of the dose calculations and are increasingly being recognised as the “gold 
standard” for predicting dose deposition in the patient [1]. 
In this study, software has been developed that enables the transfer of treatment plan information from the treatment planning system to a Monte Carlo dose calculation engine. A database of commissioned linear accelerator models 
(Elekta Precise and Varian 2100CD at various energies) has been developed using the EGSnrc/BEAMnrc Monte Carlo suite [2]. Planned beam descriptions and CT images can be exported from the treatment planning system using the 
DICOM framework. The information in these files is combined with an appropriate linear accelerator model to allow the accurate calculation of the radiation field incident on a modelled patient geometry. The Monte Carlo dose 
calculation results are combined according to the monitor units specified in the exported plan. The result is a 3D dose distribution that could be used to verify treatment planning system calculations. 
The software, MCDTK (Monte Carlo Dicom ToolKit), has been developed in the Java programming language and produces BEAMnrc and DOSXYZnrc input files, ready for submission on a high-performance computing cluster. The code 
has been tested with the Eclipse (Varian Medical Systems), Oncentra MasterPlan (Nucletron B.V.) and Pinnacle3 (Philips Medical Systems) planning systems. In this study the software was validated against measurements in 
homogenous and heterogeneous phantoms. Monte Carlo models are commissioned through comparison with quality assurance measurements made using a large square field incident on a homogenous volume of water. This study 
aims to provide a valuable confirmation that Monte Carlo calculations match experimental measurements for complex fields and heterogeneous media. 
Quasar Phantom 
 
The QuasarTM multi-purpose body phantom designed to model a 
patient thorax: it is a 30 cm wide, 20 cm high and 12 cm long acrylic 
body oval, with openings for cylindrical inserts of 2 and 8 cm 
diameter.  
3 beams were delivered to the phantom using an Elekta Precise  
linac operating at a nominal energy of 6 MV.  These beams were 
designed on a Varian Eclipse treatment planning system (using a 
pencil beam dose calculation algorithm), using CT data acquired 
from a Toshiba Aquilon/LB scanner. The beams were designed to 
allow the measurements recommended by AAPM [3] for external 
beam calculation verification: in the inner beam, 0.5 cm inside and 
outside the penumbral region, outside the beam, in the build-up 
region and along the central axis. 
12 measurements were taken: 8 without the lung inserts (a 
completely homogenous phantom) and 4 with the lung inserts and a 
2 cm diameter bone insert. Measurements were normalised to the 
central dose reference point. 
 
Elvis Phantom 
 
The Trans-Tasman Radiation Oncology Group 
performed an Australasia-wide dosimetry audit [4], 
examining the accuracy of planning and delivering 
dose to a pelvis phantom, referred to as “Elvis”. A 
treatment plan and the corresponding dose 
measurements were made available for this study.  
The “treatment” involved 4 conformal beams 
delivered to the prostate, using an Elekta Precise linac 
operating at a nominal energy of 10 MV. These beams 
were planned on a Varian Eclipse treatment planning 
system (using a pencil beam dose calculation 
algorithm), using CT data acquired from a GE HiSpeed 
scanner.  
TLD  measurements were taken at 10 locations: in the 
target volume and organs-at-risk; and in tissue and in 
bone. The simulation doses were expressed relateive 
to the dose to the near-isocentric prostate TLD. 
Results & Discussion 
Ion Chamber Measured Dose Simulated Dose Deviation 
Central measurement 1.000 1.000 ± 1.5% - 
Before Lung Insert 1.474 1.430 ± 1.8% 3.1% 
Beyond Lung Insert 0.961 0.975 ± 3.1% 1.5% 
Beyond Bone 0.590 0.611 ± 3.4% 3.4% 
Table 2. Heterogeneous Quasar Phantom Measurements 
Conclusion 
 
The study demonstrated the accuracy of Monte Carlo simulation in predicting dose in a heterogeneous phantom. This provides increased confidence that a Monte Carle dose prediction for a clinical treatment plan will more accurately 
reflect the dose delivered to the patient. IMRT radiotherapy is beginning to be adopted in the Australasian region: as more conformal treatments become the standard of care and as image-guided techniques improve treatment 
delivery,  the accuracy of dose calculation will become more important. This study is part of on-going doctoral research, that will involve the simulation and verification of complex clinical treatment plans. 
 
Agreement between measured and simulated dose was found for both phantoms: with the exception of one case, 
the deviation did not exceed the uncertainty of the dose. The simulated dose values represent the average dose 
over the measurement volume and the stated uncertainty was calculated using the standard deviation of those 
voxel values. 
This approach, while accurately representing the “noise” inherent in Monte Carlo simulation, can result in large  
dose measurement uncertainties in high dose gradient regions (such as the penumbra and build up region).  
The disagreement between the measured and simulated dose values seen at the “before lung insert” 
measurement location was larger than the uncertainty. This measurement was made in a 3 cm gap between the 
top-side of the phantom and a lung insert: within the build-up region, where dose can be incorrectly measured. 
With the exception of the “outside field” measurement, where the deviation is not significant in an absolute sense, 
the largest deviations were found in other high dose gradient regions. These regions are more suited to a distance-
to-agreement analysis. 
The Monte Carlo simulated dose more accurately predicted the measured dose in 9 of the 10 measurement 
locations in the “Elvis” phantom. The planning system over-estimated the dose to all measurement locations 
except the out of field pelvis side wall. Four of the planning system dose deviations exceeded 5%: a common 
standard of acceptable uncertainty and three of these corresponded to significant dose levels. 
The least accurate Monte Carlo prediction (3.36% deviation) in the “Elvis” measurements still provides greater 
accuracy than 80% of the treatment planning system calculations. 
